Aisling Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $316M | Buy |
|
|||||
|
2025
Q2 | $262M | Hold |
|
|||||
|
2025
Q1 | $210M | Hold |
|
|||||
|
2024
Q4 | $167M | Hold |
|
|||||
|
2024
Q3 | $154M | Hold |
|
|||||
|
2024
Q2 | $154M | Hold |
|
|||||
|
2024
Q1 | $188M | Hold |
|
|||||
|
2023
Q4 | $245M | Hold |
|
|||||
|
2023
Q3 | $160M | Hold |
|
|||||
|
2023
Q2 | $104M | Hold |
|
|||||
|
2023
Q1 | $101M | Hold |
|
|||||
|
2022
Q4 | $46.2M | Hold |
|
|||||
|
2022
Q3 | $60.3M | Hold |
|
|||||
|
2022
Q2 | $55.1M | Hold |
|
|||||
|
2022
Q1 | $61.6M | Hold |
|
|||||
|
2021
Q4 | $101M | Hold |
|
|||||
|
2021
Q3 | $284M | Hold |
|
|||||
|
2021
Q2 | $370M | Hold |
|
|||||
|
2021
Q1 | $374M | Buy |
|
|||||
|
2020
Q4 | $284M | Hold |
|
|||||
|
2020
Q3 | $150M | Hold |
|
|||||
|
2020
Q2 | $130M | Hold |
|
|||||
|
2020
Q1 | $116M | Buy |
|
|||||
|
2019
Q4 | $134M | Hold |
|
|||||
|
2019
Q3 | $82.4M | Hold |
|
|||||
|
2019
Q2 | $103M | Buy |
|